Loading...
Loading...
Gastrointestinal anthrax is a rare but potentially fatal form of anthrax infection caused by Bacillus anthracis following ingestion of contaminated meat from infected animals. The disease has a mortality rate of 25-60% if untreated and requires aggressive systemic antibiotic therapy similar to inhalational anthrax. [1-3]
The following figure illustrates the pathophysiology of anthrax infection, showing how spores germinate within macrophages and progress to systemic toxemia:
• Recent consumption of undercooked or raw meat, particularly from herbivores (sheep, goats, cattle)
• Travel to endemic areas (sub-Saharan Africa, central/southwestern Asia, southern/eastern Europe)
• Onset and progression of symptoms over 1-7 days
• Characterization of abdominal pain (location, severity, progression)
• Associated nausea, vomiting, diarrhea (bloody vs non-bloody)
• Fever pattern and constitutional symptoms
• Initial phase: nausea, vomiting, malaise, anorexia, fever
• Progressive phase: severe abdominal pain, bloody diarrhea, abdominal distention
• Oropharyngeal variant: sore throat, dysphagia, neck swelling
• Incubation period: 1-7 days (median 3 days) after ingestion [1][3-4]
• Rapid progression from initial symptoms to systemic illness within days
• Two-phase progression: initial GI symptoms followed by acute abdomen presentation
• No recent antibiotic use that might alter presentation
• No known exposure to anthrax spores or bioterrorism events
• No concurrent respiratory symptoms (to distinguish from inhalational anthrax)
• Bloody diarrhea with severe abdominal pain
• Signs of acute abdomen with rebound tenderness
• Hematemesis or coffee-ground emesis
• Rapid development of ascites
• Signs of sepsis or shock
• Massive cervical lymphadenopathy (oropharyngeal variant)
• Respiratory distress from pharyngeal edema
• Hemodynamic instability
• Signs of intestinal perforation
• Altered mental status suggesting meningitis
• Mediastinal widening on chest imaging (can occur with GI anthrax) [4]
• Any suspicion of anthrax requires immediate infectious disease consultation and CDC notification
• ICU-level care for systemic symptoms
• Surgical consultation for acute abdomen presentation
• Recent antibiotic use may alter bacterial culture results
• Immunosuppressive medications increase risk of severe disease
• Proton pump inhibitors may theoretically increase susceptibility
• IV ciprofloxacin 400 mg q12h (preferred for systemic disease) [1][5]
• IV doxycycline 100 mg q12h (alternative if ciprofloxacin contraindicated)
• Combination therapy required for systemic disease: bactericidal agent + protein synthesis inhibitor + CNS-penetrating agent [6]
• Penicillin or ampicillin as monotherapy (β-lactamase concerns) [7]
• Avoid doxycycline in pregnancy and young children when alternatives available
• Clindamycin strongly recommended as adjunctive therapy to reduce toxin production [5]
• Duration: 60 days for bioterrorism exposure, 2-3 weeks for naturally acquired disease [1]
• Switch to oral therapy once clinically stable
• NPO initially if severe nausea/vomiting or signs of acute abdomen
• Clear liquids once stable, advance as tolerated
• Monitor for GI bleeding
• Undercooked meat from herbivores (primary risk factor)
• Stored meat products from endemic areas
• Traditional meat preparations in high-risk regions
• Aggressive IV fluid resuscitation for shock
• Monitor for fluid and electrolyte imbalances from GI losses
• Blood product support if significant GI bleeding
• Respiratory: dyspnea, chest pain (rule out inhalational anthrax)
• Neurologic: headache, altered mental status, neck stiffness (meningitis)
• Genitourinary: oliguria (shock/dehydration)
• Skin: any cutaneous lesions (concurrent cutaneous anthrax)
• Constitutional: fever pattern, weight loss, night sweats
• Cardiovascular: signs of shock, fluid overload
• Pulmonary: pleural effusions can occur with GI anthrax
• Hematologic: bleeding tendency, coagulopathy
• Household members with similar symptoms (common source exposure)
• Travel companions or dining partners
• Source and preparation of suspected meat
• Occupational exposure to animal products
• Immunodeficiency syndromes
• No specific genetic predisposition to anthrax
• Immigration from endemic areas
• Traditional food practices
• Veterinary or agricultural occupation
• Consumption of undercooked meat from herbivores
• Travel to or residence in endemic areas
• Agricultural or veterinary occupation
• Bioterrorism exposure (intentional release)
• Immunocompromised state
• Advanced age
• Delayed recognition and treatment
• Sub-Saharan Africa, central/southwestern Asia
• Southern and eastern Europe
• Southwestern United States (sporadic wildlife cases)
• Acute gastroenteritis (viral, bacterial, parasitic)
• Inflammatory bowel disease exacerbation
• Ischemic bowel disease
• Appendicitis or other surgical abdomen
• Peptic ulcer disease with bleeding
• Intestinal perforation
• Mesenteric ischemia
• Sepsis from other bacterial causes
• Toxic megacolon
• Anthrax meningitis (up to 77% of systemic cases) [5]
• Massive ascites development distinguishes from typical gastroenteritis [4][8-9]
• Hemorrhagic mesenteric lymphadenitis on imaging
• Large gram-positive bacilli in blood cultures or ascites fluid
• Epidemiologic clues (meat consumption, travel history)
• Previous episodes of anthrax (rare but possible)
• Immunocompromising conditions
• Chronic GI diseases
• Previous abdominal surgeries
• Prior bowel resections
• Previous exploratory laparotomy
• Appendectomy (to distinguish from appendicitis)
• Diabetes mellitus
• Chronic kidney disease (affects antibiotic dosing)
• Heart failure (fluid management considerations)
• Vital signs: fever, tachycardia, hypotension (shock)
• Abdominal exam: diffuse tenderness, rebound tenderness, distention
• Ascites: shifting dullness, fluid wave
• Lymphadenopathy: mesenteric (not palpable), cervical (oropharyngeal variant)
• Oral or esophageal ulcers with pseudomembrane
• Massive cervical lymphadenopathy and neck edema
• Dysphagia and potential airway compromise
• Expected: fever, abdominal tenderness, ascites
• Concerning: signs of perforation, hemodynamic instability, altered mental status
• Careful abdominal examination for peritoneal signs
• Assessment for ascites
• Neurologic examination for meningeal signs
• Blood cultures (high yield - B. anthracis grows rapidly) [1-2]
• Complete blood count with differential
• Comprehensive metabolic panel
• Liver function tests
• Coagulation studies (PT/PTT/INR)
• Lactate (sepsis marker)
• Hemoconcentration from fluid losses
• Elevated transaminases
• Anemia from GI bleeding
• Thrombocytopenia and coagulopathy in severe cases [1]
• Cell count and differential
• Gram stain and culture (may show large gram-positive bacilli) [4]
• Protein, glucose, LDH
• Appearance ranges from clear to purulent
• CT abdomen/pelvis with contrast: bowel wall thickening, ascites, mesenteric lymphadenopathy [1]
• Chest X-ray: may show mediastinal widening (reported in GI anthrax) [4]
• Inflammatory changes in bowel wall
• Massive ascites
• Hemorrhagic mesenteric lymphadenitis
• Terminal ileum and cecum involvement most common [8-9]
• Stable patients with clear clinical picture
• When immediate surgical intervention is needed
• PCR testing at reference laboratories (state health departments)
• Immunohistochemistry on tissue specimens
• Serology (late in disease course, limited utility) [1]
• Gram stain of blood, ascites, or tissue (large gram-positive bacilli)
• Rapid antigen tests (if available)
• State and local health departments have access for rapid identification [3]
• Immediate notification required for suspected cases
• Generally not specific for anthrax
• May show signs of shock (tachycardia, ischemic changes)
• Monitor for arrhythmias in severe sepsis
• Hemodynamic instability
• Chest pain or respiratory symptoms
• Elderly patients or those with cardiac risk factors
• Gastrointestinal anthrax is a rare, toxin-mediated disease with high mortality
• Rapid progression from initial GI symptoms to systemic illness
• Two main presentations: oropharyngeal and lower GI tract involvement
• Mild: localized GI symptoms without systemic signs
• Moderate: systemic symptoms with hemodynamic stability
• Severe: shock, ascites, signs of perforation, or meningitis
• Typical: recent meat consumption, rapid progression, massive ascites
• Atypical: isolated oropharyngeal involvement, concurrent respiratory symptoms
• Intestinal perforation
• Anthrax meningitis (up to 77% of systemic cases)
• Septic shock and multi-organ failure
• Coagulopathy and bleeding
• Aggressive fluid resuscitation for shock
• Vasopressor support if needed
• Blood product transfusion for significant bleeding
• Airway management for oropharyngeal edema
• Primary regimen: IV ciprofloxacin 400 mg q12h + clindamycin 600-900 mg q8h + meropenem 1-2g q8h [5-6]
• Alternative: IV doxycycline 100 mg q12h (if ciprofloxacin contraindicated)
• Duration: 2-3 weeks for naturally acquired, 60 days if bioterrorism suspected
• Antitoxin therapy (if available through CDC) [6]
• Corticosteroids for severe edema or suspected meningitis [1][4]
• Supportive care per sepsis protocols
• All suspected cases of gastrointestinal anthrax
• Systemic symptoms or hemodynamic instability
• Need for IV antibiotics and monitoring
• Hemodynamic instability requiring vasopressors
• Respiratory compromise
• Signs of meningitis or altered mental status
• Multi-organ dysfunction
• Clinical improvement on oral antibiotics
• Hemodynamic stability
• Ability to tolerate oral intake
• Completion of IV antibiotic course
• Infectious disease: mandatory for all cases
• Surgery: if signs of perforation or acute abdomen
• Critical care: for severe systemic disease
• 24-48 hours after discharge for clinical reassessment
• Weekly during antibiotic course
• Infectious disease follow-up within 1 week
• Worsening abdominal pain or distention
• Recurrent fever or signs of infection
• Neurologic symptoms (headache, confusion, neck stiffness)
• Respiratory distress
• Signs of bleeding or shock
• Complete full antibiotic course (60 days if bioterrorism exposure)
• Avoid undercooked meat, especially from herbivores
• Report any household contacts with similar symptoms
• Understand that this is a reportable disease
• Symptoms typically resolve in 10-14 days with appropriate treatment [4]
• Mortality significantly reduced with early, aggressive treatment
• Long-term sequelae rare with appropriate therapy
1. Clinical Management of Potential Bioterrorism-Related Conditions. — Adalja AA, Toner E, Inglesby TV. The New England Journal of Medicine. 2015.
2. Anthrax Infection. — Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. American Journal of Respiratory and Critical Care Medicine. 2011.
3. CDC Issues Guidelines on Illnesses Associated With Intentional Release of Biologic Agents. — Ressel G. American Family Physician. 2001.
4. Anthrax. — Dixon TC, Meselson M, Guillemin J, Hanna PC. The New England Journal of Medicine. 1999.
5. Conference Report on Public Health and Clinical Guidelines for Anthrax. — Stern EJ, Uhde KB, Shadomy SV, Messonnier N. Emerging Infectious Diseases. 2008.
6. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023. — William A. Bower MD, Yon Yu PharmD, Marissa K. Person MSPH, et al United States Centers for Disease Control and Prevention. 2025.
7. ACCF/AHA/CDC Conference Report on Emerging Infectious Diseases and Biological Terrorism Threats. Task Force III: Prevention and Control of Cardiovascular Complications of Emerging Infectious Diseases and Potential Biological Terrorism Agents and Diseases. — Cooper LT, Mensah GA, Baddour LM, et al. Journal of the American College of Cardiology. 2007.
8. Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management. — Inglesby TV, O'Toole T, Henderson DA, et al. The Journal of the American Medical Association. 2002.
9. Anthrax as a Biological Weapon: Medical and Public Health Management. — Inglesby TV, Henderson DA, Bartlett JG, et al. The Journal of the American Medical Association. 1999.